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http://dx.doi.org/10.1016/j.pedneo.2Background: The clinical significance of influenza B is frequently overlooked, and reports on
influenza B pneumonia in children are limited. Therefore, the clinical features of associated
complications have rarely been reported. The aim of this study is to evaluate the clinical char-
acteristics in pediatric patients with influenza B virus-associated pneumonia.
Methods: From January 2009 to February 2012, 389 consecutive patients under 18 years old
with influenza B virus infection were enrolled into the study. Thirty-four patients were defined
as the pneumonia group by clinical symptoms and chest X-ray (CXR) findings, and 90 patients
who had laboratory data and normal CXR findings were recruited to form the nonpneumonia
group.
Results: The age of the patients in the pneumonia group was significantly younger (median of
5.3 vs. 6.6 years). The white blood cell count (median of 7.5 vs. 5.7  109 cells/L) and C-reac-
tive protein level (median of 21.1 vs. 5.7 mg/L) were higher, but the hemoglobin level was
lower (median of 12.6 vs. 13.2 g/dL) in the pneumonia group. The CXR findings revealed that
29.4% of patients had alveolar consolidation, 32.4% had interstitial infiltration, and 38.2% hadof Pediatrics, Taichung Veterans General Hospital, Number 160, Section 3, Chung-Kang Road, Tai-
ail.com (J.-D. Wang).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
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Influenza B virus-associated pneumonia 59ground glass opacity. Two of four patients with pleural effusion had a positive bacteria culture,
and both of them died.
Conclusion: Pneumonia should be considered in pediatric patients with influenza B virus infec-
tion presenting with younger age, higher white blood cell count, lower hemoglobin, and higher
C-reactive protein level. The CXR findings were varied. Patients with pleural effusion and pos-
itive bacterial culture may have more severity of clinical outcome.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Influenza virus infection is a common pediatric illness, which
causes endemic infection with an attack rate of 20e30% in
different geographic areas annually.1e4 The most common
symptoms of influenza virus infection are often self-limited,
consisting of fever, dry cough, rhinorrhea, headache, and
muscle soreness. However, some influenza virus infection
results in severe complications, such as pneumonia,
myocarditis, and encephalitis.4e6 These complications of
influenza virus infection usually attack patients who are
extremely young or old, immunocompromised, or with
underlying diseases, such as asthma or neurologic
comorbidity.6e8 Among these complications, pneumonia is
the most common and is well known in patients with influ-
enza A virus infection.6,9,10 However, the clinical charac-
teristics of influenza B virus-associated pneumonia,
especially in the pediatric population, have rarely been re-
ported.11 Therefore, in this study, we evaluated the de-
mographic characteristics, clinical presentation, laboratory
data, chest X-ray (CXR) findings, and outcomes in pediatric
patients with influenza B virus-associated pneumonia.2. Materials and Methods
After obtaining approval for the study from the Institutional
Review Board, patients under 18 years old diagnosed with
influenza B virus infection between January 2009 and
February 2012 in Taichung Veterans General Hospital, a
tertiary medical center in Taiwan, were consecutively
enrolled. Influenza B virus infection was confirmed using
the rapid antigen test for detection of influenza virus per-
formed by nasopharyngeal swab, and/or viral throat swab
culture, and/or blood sample polymerase chain reaction.
Those who had CXR were eligible to be entered into the
analysis, and were further divided into two groups, pneu-
monia and nonpneumonia groups. The enrollment process is
shown in Figure 1. The pneumonia group was defined as
patients with fever, clinical symptoms of respiratory tract
infection, and obvious infiltrations on CXR examination.2
The nonpneumonia group comprised patients with the
abovementioned symptoms and signs, but normal CXR
finding. Patients who had no blood test were excluded.
The medical charts of both investigated groups were
reviewed. The demographics, including age, gender, body
weight, clinical symptoms, and the durations of fever and
oseltamivir use were analyzed. The initial laboratory data,
including white blood cell count (WBC) with differentialcount, platelet count, hemoglobin (Hgb) level, C-reactive
protein (CRP) level, and bacterial culture reports were
collected. The films of CXR at the time of diagnosis in the
pneumonia group were reevaluated by a pediatric radiolo-
gist. The findings were described based on the following
four features: characteristics of abnormal opacities, dis-
tribution of abnormal opacities, unilateral or bilateral of
abnormal opacities, and other extrapulmonary changes.2
The characteristics of abnormal opacities were classified
into three types: alveolar consolidation, interstitial infil-
tration, and ground glass opacity (Figure 2). The distribu-
tion of abnormal opacities was divided into diffuse and
localized types, the latter of which was further classified
into central, peripheral, upper, and lower. The interpre-
tation of the characteristics and distribution of abnormal
opacities in each individual depended on the major
finding. The clinical courses including total number of days
with fever and survival outcome were assessed. Clinical
managements, including antimicrobial use, invasive me-
chanical ventilation support, and extracorporeal membrane
oxygenation application, were all investigated.
All continuous data were compared by ManneWhitney U-
test, and the categorical data were compared by the Chi-
square test within the two groups. A p value less than
0.05 was considered statistically significant.
3. Results
Among the 389 patients with influenza B virus infection, 185
patients had received CXR examination. Thirty-four pa-
tients were assigned to the pneumonia group, and 90 were
assigned to the nonpneumonia group. Pneumonia was found
in 18.4% (34/185) of influenza B patients who had under-
gone CXR imaging. The demographic characteristics and
clinical features of both groups are summarized in Table 1.
The median age of the pneumonia group was significantly
younger than that of the nonpneumonia group: 5.3 versus
6.6 years, respectively (p Z 0.029). The extreme percen-
tiles of body weight distribution, that is, <3rd percentile or
>97th percentile, were not different between the two
groups (p Z 0.795). At the time of visit, the durations of
fever were not significantly different between the two
groups. Neither oseltamivir use (5 of 28 and 9 of 80 pa-
tients, pZ 0.513) nor doses (8.0 and 8.0 doses, pZ 0.451)
before the visit was significantly different between the
pneumonia and nonpneumonia groups. The incidences of
symptoms in the pneumonia and nonpneumonia groups
were as follows: fever, 100% and 94.4%; cough, 97% and
94.4%; and rhinorrhea/nasal congestion, 70.6% and 81.1%,
Figure 1 Flowchart of patient selection.
60 C.-Y. Liu et alrespectively. The incidence of shortness of breath was
14.7% in the pneumonia group and 5.6% in the non-
pneumonia group (p Z 0.135). The incidence of abdominal
symptoms including abdominal pain, nausea, vomiting and/
or diarrhea was 41.2% for the pneumonia group and 22.2%
for the nonpneumonia group (p Z 0.059).
The laboratory data and clinical outcomes of both
groups are listed in Table 2. The WBC of patients in the
pneumonia group was significantly higher than that in the
nonpneumonia group (7.5  109 vs. 5.7  109 cells/L,
p Z 0.017). The proportion of leukopenia (WBC
<4.0  109 cells/L) was 14.5% (18/124) for all patients,
5.9% (2/34) in the pneumonia group, and 17.8% (16/90) in
the nonpneumonia group. The Hgb level in the pneumonia
group was significantly lower than that in the non-
pneumonia group, 12.6 and 13.2 g/dL, pZ 0.03. According
to the normal range of Hgb level by age, 29.4% (10 of 34)
and 11.1% (10 of 90) of patients had anemia in the pneu-
monia group and nonpneumonia group, respectively(p Z 0.028). The CRP level was also significantly higher in
the pneumonia group than in the nonpneumonia group, 21.1
versus 5.7 mg/L (pZ 0.002). Excluding the data of patients
with a positive result of bacterial culture, the CRP level was
still significantly higher in the pneumonia group, 18.0 versus
5.7 mg/L (p Z 0.010). In the pneumonia group, four pa-
tients had a positive result of bacterial culture. One had a
blood culture which was positive for Streptococcus pneu-
moniae, and the other three cultures were from tracheal
aspirates, which included two Staphylococcus aureus iso-
lates and one Streptococcus pneumoniae. In the non-
pneumonia group, none had a positive result of bacterial
culture.
The CXR findings in the pneumonia group are summa-
rized in Table 3. With regard to the main pattern of char-
acteristics of abnormal opacities, these were varied: 29.4%
of patients had alveolar consolidation, 32.4% had intersti-
tial infiltration, and 38.2% had ground glass opacity. Four
patients had pleural effusion. Among these four patients,
Figure 2 Representative chest X-ray findings of patients with influenza B virus-associated pneumonia. (A) Alveolar consolidation;
(B) interstitial infiltration; (C) ground glass opacity; (D) diffuse distribution; (E) localized central distribution; (F) localized right
lower lung field; (G) pleural effusion, with Staphylococcus aureus from tracheal aspirate; (H) pleural effusion, with Streptococcus
pneumoniae from tracheal aspirate.
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pneumoniae cultured from tracheal aspirates, but no pa-
tients had positive culture reports of blood or pleural
effusion.
The study further investigated the total durations of
fever and antibiotic use in patients with influenza B virus
infection-associated pneumonia. Based on the data from 23
patients, there was no significant difference in the total
number of days with fever between patients with and
without antibiotic treatment (5.0  5.4 days, 17 patients
with antibiotic use; 4.5  2.9 days, 6 patients without
antibiotic use; p Z 0.245).
Three patients required endotracheal tube intubation.
One was a 7-year-old girl who had a history of seizure andpresented with status epilepticus, and was then intubated.
She recovered without other complications. The other two
patients, who died, were previously healthy. They were
both intubated because of severe respiratory distress and
then further depended on extracorporeal membrane
oxygenation support.
Among the four patientswith pleural effusion, the first one
was a 6-year-old boy who had Streptococcus pneumoniae
cultured from tracheal aspirates. He received treatment
with peramivir, cefotaxime, and clindamycin, and died of
acute respiratory distress syndrome on the 6th day of
hospitalization. The second one was a 14-year-old girl
with methicillin-resistant Staphylococcus aureus cultured
from tracheal aspirates. She received treatment with
Table 1 Demographic characteristics and clinical features of patients with influenza B virus infection.
Pneumonia Nonpneumonia p
n Z 34 n Z 90
Age (y) 5.3  3.3 6.6  4.4 0.029
Sex (boy/girl) 19/15 49/41 1.000
Body weight (n, percentile by age) 0.795
<3rd percentile 1 5
3rde97th percentile 31 80
>97th percentile 2 4
No. of days with fever before visit 3.5  3.5 3  3.8 0.581
Symptom, n (%)
Cough 33 (97.0%) 85 (94.4%) 1.000
Sore throat 8 (23.5%) 22 (24.4%) 1.000
Rhinorrhea or nasal congestion 24 (70.6%) 73 (81.1%) 0.306
Shortness of breath 5 (14.7%) 5 (5.6%) 0.135
Myalgia 8 (23.5%) 27 (30.0%) 0.624
Neurological symptoms* 6 (17.6%) 18 (20.0%) 0.967
Abdominal symptomsy 14 (41.2%) 20 (22.2%) 0.059
Drug history
Oseltamivir use (yes/no) 5/23 9/71 0.513
Dose of oseltamivir use 8.0  2.9 8.0  2.2 0.451
Underlying disease, n (%) 12 (35.3%) 16 (17.8%) 0.066
Asthma or atopic disease 2 7z
Biliary atresia 1 1
Cardiovascular disease 3 1
Malignancy 0 1
Neurological or developmental problem 2 1z
Others 4 6
Data are expressed as median  SD.
* Neurological symptoms included headache and/or seizure.
y Abdominal symptoms included abdominal pain, nausea, vomiting and/or diarrhea.
z One patient had both asthma and seizure.
62 C.-Y. Liu et alperamivir, cefepime, and fosfomycin, and died ofmyocarditis
and multiple organ failure on the 12th day of hospitalization.
The other two patients with pleural effusion were ventilator-
independent, and therewas nopositive bacterial culture fromTable 2 Laboratory data and clinical outcomes of patients wit
Pneumoni
n Z 34
WBC ( 109 cells/L) 7.5  4
Neutrophil (%) 63.1  2
Lymphocyte (%) 22.6  1
Leukopenia* (%) 5.9
Hgb (g/dL) 12.6  1
Platelet ( 109/L) 215.5  1
CRP (mg/L) 21.1  7
No. of positive bacterial culturey (%) 4 (11.8)
No. of Intubation (%) 3 (8.8)
No. of ECMO (%) 2 (5.9)
No. of deaths (%) 2 (5.9)
The data are expressed as medianSD.
* Leukopenia means WBC <4.0  109 cells/L.
y Culture from blood and/or tracheal aspirate.either blood or pleural effusion. One received combined
therapy of 5-day oseltamivir and 7-day cefotaxime plus clin-
damycin. The other one did not receive any antibiotics. Both
of them recovered without any complications.h influenza B virus infection.
a Nonpneumonia p
n Z 90
.0 5.7  3.1 0.017
2.1 62.0  16.7 0.889
6.9 25.2  14.0 0.275
17.8 0.151
.59 13.2  1.32 0.030
02.5 198.0  75.0 0.373





Table 3 Initial chest X-ray findings of 34 patients with
influenza B virus-associated pneumonia.
Chest X-ray findings No. of patients Percentage
Characteristics of abnormal opacities
Alveolar consolidation 10 29.4%
Interstitial infiltration 11 32.4%







Unilateral or bilateral abnormal opacities
Unilateral, Right side 12 35.3%
Unilateral, Left side 0 0.0%
Bilateral 22 64.7%
Other extrapulmonary findings
Pleural effusion 4 11.8%
Influenza B virus-associated pneumonia 634. Discussion
The influenza B virus was considered to be less virulent
and less widespread than the influenza A virus. Thus,
previous clinical studies and public health policies have
tended to place a greater emphasis on the more patho-
genic influenza A virus.12,13 However, recent epidemio-
logic studies have demonstrated that influenza B virus, in
a similar manner to influenza A virus, is also capable of
causing severe infection and invasive complications.14,15
In the present study, pneumonia was found in 18.4% of
influenza B patients who had undergone CXR, which was
compatible with a previously reported rate of 2e20%.2,5
As there are few reports on infection rates in the pedi-
atric population, it is difficult to assess the true mortality
rate of pediatric influenza B virus-associated pneu-
monia.2,11,16 Most patients recovered after adequate
treatment, but the mortality rate could be as high as
22e94% if the patients’ conditions deteriorate to acute
respiratory distress syndrome.14,17 In this study, most
pneumonia patients recovered with no sequelae, but the
patients who developed acute respiratory distress syn-
drome expired.
The peak age of influenza B virus infection with
concomitant pneumonia in children ranged from younger
than 1 year to 6 years in different geographic areas.2,5,14
The present study also showed that the median age of the
pneumonia group was significantly younger. Moreover,
several reports had shown that most serious or fatal cases
of influenza B virus-associated pneumonia were not linked
with chronic medical conditions.15,18 In the present study,
the percentages of patients with underlying disease in the
two investigated groups were not significantly different. In
addition, two deceased patients were previously healthy.
Therefore, although greater vigilance in patients with a
chronic medical condition is warranted, previously healthy
patients should not be presumed to have lower risks of
morbidity and mortality.Early administration of oseltamivir within 48 hours after
onset of flulike symptoms is recommended for children at
high risk of influenza complications in order to reduce
morbidity and mortality.19 However, the use of oseltamivir
against influenza B virus has been reported to have a
relatively low clinical effectiveness.20,21 Our results also
showed no significant difference in oseltamivir use between
pneumonia and nonpneumonia patients before the visit.
It is important to identify clues that may indicate the
development of complications in patients with influenza B
virus infection. Gastrointestinal symptoms, which were
common symptoms in children with pneumonia,22 accoun-
ted for the largest proportion of symptoms in the pneu-
monia group of the current study. With regard to the
laboratory findings, the median WBC was higher in the
pneumonia group, although leukopenia rates were not
significantly different between the two investigated
groups. Anemia is relevant to lower respiratory tract
infection and for more serious influenza infection.23,24
Furthermore, a higher CRP level is considered to be a
predictor of bacterial infection among patients with an
influenza-like illness.25,26 The present study showed lower
Hgb and higher CRP level in the pneumonia group regardless
of positive or negative bacterial culture reports. Although
these results suggest that influenza B virus-associated
pneumonia should be considered in patients with higher
WBC, lower Hgb, and higher CRP level, the overlapped
ranges of these parameters in the two groups were large.
Further studies with a larger number of patients are needed
to elucidate the precise roles of these parameters.
The CXR findings of patients with influenza virus-
associated pneumonia are inconsistently described.2,15,27e29
In the present study, the CXR findings of pediatric patients
with influenza B virus-associated pneumonia were quite var-
ied. Regarding the extrapulmonary changes, pediatric pa-
tients with swine flu (H1N1) pneumonia who presented with
pleural effusion that could develop without bacterial coin-
fectionandhadamildclinical course.29 Incontrast, twoofour
four patients with pleural effusion and positive bacterial
culture from tracheal aspirates were intubated and died.
Therefore, patients who present with pleural effusion and
positive bacterial culture from tracheal aspirates may have a
risk of mortality.
Influenza virus-associated pneumonia could be classified
as primary viral pneumonia, coexisting viral and bacterial
pneumonia, and secondary bacterial pneumonia.2,25,30
No clear consensus has been reached about whether
patients with viral pneumonia need to be treated with an-
tibiotics.2,25 In the present study, there was no significant
difference in total number of days with fever in pneumonia
patients with and without antibiotic administration.
Because of the limited number of patients with a positive
bacterial culture report of blood or tracheal aspirates in our
study, the timing of combined antiviral and antibacterial
therapy for influenza B virus-associated pneumonia should
be further investigated.
There were several limitations in this study. The flow-
chart of patient selection shows that the patients received
CXR and blood examinations. Thus, the data only represent
patients with influenza B virus infection and more serious
conditions. In addition, the present study only included the
initial clinical features, laboratory data, and CXR findings,
64 C.-Y. Liu et alwhich might change with the clinical course. Furthermore,
because the review period was 3 years, different strains of
influenza B virus may have circulated in different flu sea-
sons. Thus, the clinical features in patients with influenza B
virus infection may be different from year to year.
In conclusion, pneumonia should be considered in pedi-
atric patients with influenza B virus infection and the
following risk factors: younger age, higher WBC, lower Hgb,
and higher CRP level. The CXR findings were varied. Pa-
tients with pleural effusion and positive bacterial culture
may have a more severe clinical outcome.
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